MedTrace Logo

Microwave Ablation of Breast Tumors

NCT04828044 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-04-01

No results posted yet for this study

Summary

The purpose of this protocol is to pathologically evaluate the amount of destruction of cancer cells by Microwave Ablation (MWA) in primary breast tumors.

Conditions

Interventions

DEVICE

Microwave Ablation/ Coagulation Arm

An 11-gauge microwave probe from MedWaves, Inc., will be placed in the tumor. An ablation lesion will then be generated at the appropriate power (10-35 watts) to maintain up to 130C degrees at the MW applicator tip thermocouple for 10 minutes duration. Palpation and/or ultrasound may be used to place the MWA needle and monitor the progress of the microwave ablation.

Sponsors & Collaborators

  • St. Joseph Hospital of Orange

    lead OTHER

Principal Investigators

  • Lawrence Wagman, M.D. · St. Joseph Hospital of Orange

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04828044 on ClinicalTrials.gov